For help on how to get the results you want, see our search tips.
365 results
Keyword Remove keyword
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Maximum residue limits Remove Maximum residue limits filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Human medicine European public assessment report (EPAR): Ablavar (previously Vasovist)
gadofosveset trisodium, Magnetic Resonance Angiography
Date of authorisation: 03/10/2005, Revision: 10, Withdrawn, Last updated: 14/11/2011 -
List item
Human medicine European public assessment report (EPAR): Acomplia
rimonabant, Obesity
Date of authorisation: 19/06/2006, Revision: 8, Withdrawn, Last updated: 30/01/2009 -
List item
Veterinary medicine European public assessment report (EPAR): Acticam
meloxicam, Dogs; Cats
Date of authorisation: 09/12/2008,
, Revision: 9, Withdrawn, Last updated: 24/03/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Activyl Tick Plus
indoxacarb, permethrin, Dogs
Date of authorisation: 09/01/2012, Revision: 9, Withdrawn, Last updated: 04/10/2022 -
List item
Veterinary medicine European public assessment report (EPAR): Advasure
E2 glycoprotein of classical swine fever virus, Pigs
Date of authorisation: 02/02/2001, Revision: 5, Withdrawn, Last updated: 17/03/2008 -
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Agenerase
amprenavir, HIV Infections
Date of authorisation: 20/10/2000, Revision: 18, Withdrawn, Last updated: 21/06/2011 -
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Human medicine European public assessment report (EPAR): Alisade
fluticasone furoate, Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
Date of authorisation: 06/10/2008, Revision: 4, Withdrawn, Last updated: 18/10/2011 -
List item
Human medicine European public assessment report (EPAR): Allex
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Withdrawn, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Alpivab
Peramivir, Influenza, Human
Date of authorisation: 13/04/2018,
, Revision: 2, Withdrawn, Last updated: 09/12/2020
-
List item
Human medicine European public assessment report (EPAR): Altargo
retapamulin, Impetigo; Staphylococcal Skin Infections
Date of authorisation: 24/05/2007, Revision: 15, Withdrawn, Last updated: 15/03/2019 -
List item
Human medicine European public assessment report (EPAR): Angiox
Bivalirudin, Acute Coronary Syndrome
Date of authorisation: 20/09/2004, Revision: 22, Withdrawn, Last updated: 14/09/2018 -
List item
Human medicine European public assessment report (EPAR): Arepanrix
split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs., Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 23/03/2010,
, Revision: 1, Withdrawn, Last updated: 25/10/2011
-
List item
Human medicine European public assessment report (EPAR): Ariclaim
duloxetine, Diabetic Neuropathies
Date of authorisation: 11/08/2004, Revision: 26, Withdrawn, Last updated: 07/08/2018 -
List item
Human medicine European public assessment report (EPAR): Arzerra
Ofatumumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 19/04/2010, Revision: 16, Withdrawn, Last updated: 10/05/2019 -
List item
Human medicine European public assessment report (EPAR): Atripla
efavirenz, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 13/12/2007, Revision: 36, Withdrawn, Last updated: 21/01/2022 -
List item
Human medicine European public assessment report (EPAR): ATryn
Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006,, 
, Revision: 16, Withdrawn, Last updated: 02/07/2019
-
List item
Human medicine European public assessment report (EPAR): Avaglim
rosiglitazone, glimepiride, Diabetes Mellitus, Type 2
Date of authorisation: 27/06/2006, Revision: 11, Withdrawn, Last updated: 12/08/2011 -
List item
Human medicine European public assessment report (EPAR): Avandamet
rosiglitazone, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 20/10/2003, Revision: 16, Withdrawn, Last updated: 08/06/2016 -
List item
Human medicine European public assessment report (EPAR): Avandia
rosiglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 11/07/2000, Revision: 23, Withdrawn, Last updated: 08/06/2016 -
List item
Human medicine European public assessment report (EPAR): Azacitidine Celgene
azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 02/08/2019, Revision: 2, Withdrawn, Last updated: 04/08/2021 -
List item
Human medicine European public assessment report (EPAR): Bextra
valdecoxib, Arthritis, Rheumatoid; Osteoarthritis; Dysmenorrhea
Date of authorisation: 27/03/2003, Revision: 2, Withdrawn, Last updated: 03/02/2010 -
List item
Human medicine European public assessment report (EPAR): BindRen
colestilan, Hyperphosphatemia
Date of authorisation: 21/01/2013,, Revision: 2, Withdrawn, Last updated: 01/04/2015
-
List item
Human medicine European public assessment report (EPAR): Biograstim
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008,
, Revision: 8, Withdrawn, Last updated: 19/01/2017